Key facts
- Notable investors include PointOne Capital, DBT-ILS Bioincubator, NSRCEL-IIMB, Startup Incubation and Innovation Centre, Startup India Seed Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Genomiki
- ·The full record, as it builds
Funding rounds
No funding rounds for Genomiki are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Genomiki
Developer of genomic informatics services designed to support healthcare and research through advanced genetic analysis. The company offers diagnostic and screening services powered by artificial intelligence and bioinformatics, supports detection of rare and inherited disorders, integrates genomic data with clinical workflows, and provides customized analysis for research projects, enabling healthcare providers, laboratories, and research institutions to achieve accurate diagnosis, improve medical decision-making, and advance personalized medicine.
- Sector
- Healthcare
- HQ
- Greater Noida, India
- Founded
- 2021
- Website
- genomiki.com/
- Ownership
- Privately Held (backing)
Genomiki doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Genomiki shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Genomiki in its N-PORT filings yet. We sweep new filings monthly.